Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) FCF Margin (2019 - 2025)

aTYR PHARMA's FCF Margin history spans 6 years, with the latest figure at 10796.32% for Q3 2025.

  • For Q3 2025, FCF Margin changed N/A year-over-year to 10796.32%; the TTM value through Dec 2025 reached 32664.74%, down 322474.0%, while the annual FY2025 figure was 32664.74%, 322474.0% down from the prior year.
  • FCF Margin reached 10796.32% in Q3 2025 per ATYR's latest filing, down from 9530.64% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 110.61% in Q4 2022 to a low of 10796.32% in Q3 2025.
  • Average FCF Margin over 4 years is 5825.82%, with a median of 6198.18% recorded in 2023.